AllQuantitative Report
logoArgus•March 03, 2021

HAE: Lowering target price to $130.00

Symbols
HAE
Sector(s)
Healthcare
Rating
Current Price
$85.07
Price Target
Earnings Estimate
Summary

Haemonetics Corp sells products used to process, handle, and analyze blood. The firm sells products in four categories: Plasma, Hemostasis

Upgrade to begin using premium research reports and get so much more.

Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
Upgrade

Actions

Download Full Report

Related Reports

View more related reports